Clearside Biomedical, Inc 10-K for FY2023
Clearside Biomedical, Inc. (CLSDQ)
10-K
2024-03-12
For: 2023-12-31
View Original
Added on
April 06, 2026
About this 10-K
Clearside Biomedical, Inc filed this 10-K on March 12, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $8.23M
- up 519.9% from $1.33M a year earlier
- Net loss
- $32.49M
- compared with a net loss of $32.95M a year earlier
- Diluted EPS
- -$0.53
- compared with -$0.55 a year earlier